Micheál Martin (Minister for Foreign Affairs), Hugh Cooney (Chairman Enterprise Ireland), An Taoiseach Brian Cowen, (Head of Irish Government), Nancy Horan (Director – BioTector Analytical Systems Ltd), Joe O'Shea (Director, Corporate Development – Danaher Corporation), Martin Horan (Managing Director - BioTector Analytical Systems Ltd), Richard Leggett (Principal Scientist - Hach Company), Jeff Throckmorton (Vice President Global Innovation Hach-Lange, President Hach Homeland Security Technologies – Hach Company).
BioTector Analytical Systems has recently announced a distribution agreement with Colorado (US)-based Hach Company. Hach and Hach Lange will serve as the exclusive distributor of the BioTector range of on-line liquid analyzers in the United States, Canada, Mexico, Brazil and Europe. The product will be sold in these markets under the name: Hach BioTector TOC analyzer. The agreement does not include the Irish market, as BioTector has a number of Irish Distributors who look after the local market.
The distribution agreement was announced during a Trade and Investment Mission to the U.S. led by the Taoiseach Brian Cowen. The Mission is organized by Enterprise Ireland, the Irish state agency responsible for the development and promotion of the indigenous Irish business sector.
BioTector’s on-line liquid analyzers are used in a variety of industrial applications, including dairy processing, chemical processing, oil refineries, municipal treatment plants, pharmaceutical manufacturing, airport surface water analysis, breweries, and pulp and paper manufacturing. The company’s patented oxidation technology—a two-stage advanced oxidation method—overcomes the limitations of traditional on-line analyzers and offers customers an accurate, reliable and low maintenance solution to their on-line analysis needs.
“We’re very pleased to enter into this partnership with Hach Company,” said Martin Horan, BioTector’s Managing Director. “This distribution agreement with a leading U.S. company like Hach—a significant endorsement of our technology— offers Hach customers a robust on-line liquid analysis technology that overcomes the limitations of most competing systems, which are better suited for lab rather than industrial environments. Hach’s systems, like ours, are designed specifically for quality, accuracy and simplicity, and it is this shared ethos in high standards and customer satisfaction that we believe will drive the success of this partnership.”
“We’re very pleased to be able to offer the BioTector TOC analyzer to Hach customers,” said Terry Stange, Hach Business Unit Director. “These products offer 99.7 percent uptime, +/- 3 percent accuracy, are entirely self-cleaning, and can analyze samples up to a thousand times larger than those of competing products. This will provide our customers with the benefits of reliability, measurement confidence, low maintenance and high capacity.”
Ferring commits $10 million to March of Dimes to expand research needed to end preterm birth - (March of Dimes Foundation) Ferring Pharmaceuticals and the March of Dimes announced today that Ferring has committed $10 million to support the network of...